Q&A Briefing

In this session Wellnex Life MD Zack Bozinovski, CEO George Karafotias and new Board appointment Andrew Vidler discussed the key highlights:

  • How the transformative acquisition of leading topical pain relief brand Pain Away complements Wellnex Life’s position and growth strategy whilst adding immediate scale
  • Why global and domestic industry leaders like Haleon, Chemist Warehouse, Coles and Woolworths choose to partner with Wellnex Life
  • What the reset leadership team is focused on

Recorded on 14th December 2023 at 12pm (AEDT).

Join the next Wellnex Life webcast

Featured Speakers

Zack Bozinovski

Managing DirectorWellnex Life (ASX: WNX)

Zack is a highly successful and seasoned executive in the Australian retail industry with over 35 years’ experience within FMCG and Pharmaceutical companies in Australia and internationally. Zack has previously held senior positions at Uncle Tobys/Goodman Fielder, PepsiCo and Sigma and successfully developed and established many brands in the Australian retail sector. Zack most recently held the position of Managing Director at Brands Solutions Australia. Zack was also a co-founder of Voost Vitamins, recently sold to Proctor & Gamble.

Andrew Vidler

Independent Non-Executive DirectorWellnex Life (ASX: WNX)

Andrew Vidler has comprehensive experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years’ experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across many roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business. For the last 4 years Andrew worked for API Limited (now Wesfarmers Health) where he was responsible for the Priceline retail and Priceline pharmacy business. Andrew has an excellent track record of building strong team cultures while ensuring they say focused on the marketplace and building customers with an active preference for the products, brands and retailers he oversees.

 

Geoge Karafotias

Chief Executive OfficerWellnex Life (ASX: WNX)

George is a specialist in restructuring, reinventing and implementing turnaround strategies for various ASX-listed companies with great success. His extensive experience includes an established track record with publicly-traded businesses, predominantly in senior executive positions. He is also a non-executive Director of Perpetual Resources Limited (ASX:PEC), and holds a Bachelor of Commerce degree from the University of Adelaide.

 

Reach Corporate provides Corporate Advisory Services, including managing investor communications on behalf of Wellnex Life Limited and may receive fees for its services.

Any advice contained within this presentation is general advice and does not consider your personal circumstances, you should consider whether it is appropriate for you. The information we are giving you is for educational purposes only. “Investing is about understanding your risk” and every time you invest in the share market there is a risk of loss.

Past performance is not a reliable indicator of future performance.

This update is being hosted by Reach Markets Pty Ltd (CAR of AFSL 333297) and Reach does not assume responsibility for the accuracy or completeness of any information provided, and any communication from Reach has been prepared with all reasonable care and may be based on unverified information obtained from sources believed to be reliable. However, except to the extent required by law, Reach including its representatives, employees, agents or contractors are not liable to you for any loss or damage resulting directly or indirectly from access to information and do not accept any responsibility for errors and omissions, nor make any warranty or representation as to the reliability, suitability, confidentiality, accuracy, completeness or timeliness of information as it may change without notice and so Reach has no obligation to keep the information current.

Forward Looking Statements relate to intentions, future acts and events that are only predictions and are subject to risks, uncertainties and assumptions, which are outside the control of Reach. These may include commodity prices, currency fluctuations, economic and financial market conditions in various countries and regions, environmental risks and legislative, fiscal or regulatory developments, political risks, project delay or advancement, approvals and cost estimates. Actual values, results or events may be materially different to those expressed or implied and given these uncertainties, readers are cautioned not to place reliance on Forward Looking Statements. Information and views from third parties may be produced solely for convenience and are not endorsed nor reflective of Reach’s position.

latest other webcasts

Prescient Therapeutics (ASX: PTX) Webcast Replay

Felix Gold (ASX: FXG) Webcast Replay

Prescient Therapeutics (ASX: PTX) Q&A Investor Update